PCR51 Reassessing the Acceptability of Risk of Death Associated With Gene Therapy for Duchenne Muscular Dystrophy: A Qualitative Study to Inform Updating a Quantitative Instrument
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1986
https://www.valueinhealthjournal.com/article/S1098-3015(22)04191-2/fulltext
Title :
PCR51 Reassessing the Acceptability of Risk of Death Associated With Gene Therapy for Duchenne Muscular Dystrophy: A Qualitative Study to Inform Updating a Quantitative Instrument
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04191-2&doi=10.1016/j.jval.2022.09.1986
First page :
Section Title :
Open access? :
No
Section Order :
11532